Par Drugs & Chemicals Faces Intense Selling Pressure Amid Significant Price Declines
Par Drugs & Chemicals Ltd is experiencing significant selling pressure, marked by consecutive losses and a new 52-week low. The stock has declined sharply over various time frames, underperforming compared to the Sensex. It is trading below all major moving averages, reflecting ongoing challenges in the market.
Par Drugs & Chemicals Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 5.00% in just one day. Over the past week, the stock has dropped 19.45%, and its performance over the last month reveals a staggering decrease of 28.14%. In comparison to the Sensex, which has shown a slight increase of 0.32% today, Par Drugs & Chemicals has underperformed significantly. The stock's performance over three months reflects a decline of 53.42%, while the Sensex has only decreased by 1.76%. Year-to-date, the stock is down 32.24%, contrasting sharply with the Sensex's modest decline of 2.47%.
Today, Par Drugs & Chemicals hit a new 52-week low of Rs. 134.78, indicating a challenging market position. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further highlighting the prevailing selling sentiment. Factors contributing to this selling pressure may include broader market trends and specific challenges within the chemicals sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
